The FDA has expanded the approval of Valtoco (diazepam nasal spray) to include treatment of seizure clusters in patients aged 2 to 5 years.

The risks of dependence and withdrawal increase with longer treatment duration and higher daily dose. Although VALTOCO is indicated only for intermittent use, if used more frequently than ...

The Food and Drug Administration (FDA) has expanded the approval of Valtoco ® (diazepam nasal ... supporting the effectiveness of the dosing regimen for patients aged 2 to 5 years.